viomedo Provides Access to Innovative Treatment Methods

viomedoInformation overload is a common and significant problem with most existing clinical trial search platforms or applications. viomedo makes clinical trial information easily accessible to everybody based on a variety of criteria and by following patient-centric approaches. So far, viomedo online platform aggregates about close to 2.000 clinical trials conducted in Germany.

viomedo's founder Alexander Puschilov mentioned: "We are convinced, that everybody has the right to get the best possible therapy! This is why we’ve built viomedo to help patients discover and benefit from innovative treatment methods that were previously accessible only to a few lucky patients."

viomedo's reported main functionality and features are:

  • The platform aggregates information about close to 2.000 open trials in Germany that are both investigator and industry initiated that cover most known diseases. Patients can find the trial with a convenient search by their disease name or select a disease from a list.
  • Patients see the trial’s most relevant information in a way that they can understand. That empowers them to decide independently if the trial is worth participating in.
  • Patients can contact the closest clinical trial site location conveniently via viomedo. After a personal screening interview with the investigator they can make an educated decision about their participation.

viomedo's team developed the platform using the input, requirements and the feedback of the patients enrolled in clinical trials and the suggestions and expectations of healthcare professionals. "We want to bring transparency into the field of clinical-studies in order to connect patients and providers," Puschilov says. "And there is definitely a need for patient-centered platforms like viomedo. The collected clinical trials information represented on the platform combined with the platform's usability frames makes viomedo the central, most advanced and ambitious focal point for clinical research in Germany."

For further information, please visit:
http://www.viomedo.de

About viomedo
viomedo is a free platform, which aggregates and interprets information about clinical trials online. It was founded by Alexander Puschilov, Stefan Nietert and Tim Seithe in 2015 in Berlin. They have deep expertise in the fields of technology, medicine and digital health. It covers close to 2.000 trials that are open to patients in Germany. Because viomedo solves a great problem for patients and researchers alike, it has gathered support from leading clinicians.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...